Abstract:A series of novel pleuromutilin derivatives were designed and synthesized with 1,2,4-triazole as the linker connected to benzoyl chloride analogues under mild conditions. The in vitro antibacterial activities of the synthesized derivatives against four strains of Staphylococcus aureus (MRSA ATCC 43300, ATCC 29213, AD3 and 144) were tested by the broth dilution method. Most of the synthesized derivatives displayed potent activities, and 22-(3-amino-2-(4-methyl-benzoyl)-1,2,4-triazole-5-yl)-thioacetyl)-22-deoxypleuromutilin (compound 12) was found to be the most active antibacterial derivative against MRSA (MIC = 0.125 μg/mL). Furthermore, the time-kill curves showed compound 12 had a certain inhibitory effect against MRSA in vitro. The in vivo antibacterial activity of compound 12 was further evaluated using MRSA infected murine thigh model. Compound 12 exhibited superior antibacterial efficacy than tiamulin. It was also found that compound 12 had no significant inhibitory effect on the proliferation of RAW264.7 cells. Compound 12 was further evaluated in CYP450 inhibition assay and showed moderate inhibitory effect on CYP3A4 (IC50 = 3.95 μM). Moreover, seven candidate compounds showed different affinities with the 50S ribosome by SPR measurement. Subsequently, binding of compound 12 and 20 to the 50S ribosome was further investigated by molecular modeling. Three strong hydrogen bonds were formed through the interaction of compound 12 and 20 with 50S ribosome. The binding free energy of compound 12 and 20 with the ribosome was calculated to be -10.7 kcal/mol and -11.66 kcal/mol, respectively.

Tetracyclic Indolines As a Novel Class of Β-Lactam-selective Resistance-Modifying Agent for MRSA.

Synthesis and antibacterial activity of novel icariin derivatives.

Tryptoline-based benzothiazoles re-sensitize MRSA to β-lactam antibiotics.

Bio-inspired Synthesis Yields a Tricyclic Indoline That Selectively Resensitizes Methicillin-Resistant Staphylococcus Aureus (MRSA) to Β-Lactam Antibiotics

Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection

Structure–activity Relationship Studies of [1,2,5]Oxadiazolo[3,4-B]pyrazine-containing Polymyxin-Selective Resistance-Modifying Agents

Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a

Structure-activity relationship studies of thiazole agents with potential anti methicillin-resistance Staphylococcus aureus (MRSA) activity

2-Hydroxypropyl Group Linked Derivatives of Indole Azoles As Potential Multifunctional Antibacterial Candidates for Effectively Inhibiting the Activity of MRSA and Responding Inflammatory Factors.

An unexpected discovery toward novel membrane active sulfonyl thiazoles as potential MRSA DNA intercalators

Indole-nitroimidazole Conjugates As Efficient Manipulators to Decrease the Genes Expression of Methicillin-Resistant Staphylococcus Aureus.

Marinopyrrole Derivatives As Potential Antibiotic Agents Against Methicillin-Resistant Staphylococcus Aureus (Ii)

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

The effect of novel β-lactam derivatives synthesized from substituted phenethylamines on resistance genes of MRSA isolates

Discovery and Initial Structure-Activity Relationships of N-benzyl Tricyclic Indolines As Antibacterials for Methicillin-Resistant Staphylococcus Aureus.

An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a

A New Class of Multi-Armed Antibiotics with Low Risk of Resistance

Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSA

Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome

Benzimidazole analogues as efficient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies

Characterization of compound A, a novel lincomycin derivative active against methicillin-resistant Staphylococcus aureus